Correlation Between Eyepoint Pharmaceuticals and Alnylam Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Eyepoint Pharmaceuticals and Alnylam Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eyepoint Pharmaceuticals and Alnylam Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eyepoint Pharmaceuticals and Alnylam Pharmaceuticals, you can compare the effects of market volatilities on Eyepoint Pharmaceuticals and Alnylam Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eyepoint Pharmaceuticals with a short position of Alnylam Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eyepoint Pharmaceuticals and Alnylam Pharmaceuticals.
Diversification Opportunities for Eyepoint Pharmaceuticals and Alnylam Pharmaceuticals
0.41 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Eyepoint and Alnylam is 0.41. Overlapping area represents the amount of risk that can be diversified away by holding Eyepoint Pharmaceuticals and Alnylam Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Alnylam Pharmaceuticals and Eyepoint Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eyepoint Pharmaceuticals are associated (or correlated) with Alnylam Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Alnylam Pharmaceuticals has no effect on the direction of Eyepoint Pharmaceuticals i.e., Eyepoint Pharmaceuticals and Alnylam Pharmaceuticals go up and down completely randomly.
Pair Corralation between Eyepoint Pharmaceuticals and Alnylam Pharmaceuticals
Given the investment horizon of 90 days Eyepoint Pharmaceuticals is expected to under-perform the Alnylam Pharmaceuticals. In addition to that, Eyepoint Pharmaceuticals is 1.66 times more volatile than Alnylam Pharmaceuticals. It trades about -0.25 of its total potential returns per unit of risk. Alnylam Pharmaceuticals is currently generating about -0.07 per unit of volatility. If you would invest 26,659 in Alnylam Pharmaceuticals on September 1, 2024 and sell it today you would lose (1,352) from holding Alnylam Pharmaceuticals or give up 5.07% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Eyepoint Pharmaceuticals vs. Alnylam Pharmaceuticals
Performance |
| Timeline |
| Eyepoint Pharmaceuticals |
| Alnylam Pharmaceuticals |
Eyepoint Pharmaceuticals and Alnylam Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Eyepoint Pharmaceuticals and Alnylam Pharmaceuticals
The main advantage of trading using opposite Eyepoint Pharmaceuticals and Alnylam Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eyepoint Pharmaceuticals position performs unexpectedly, Alnylam Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Alnylam Pharmaceuticals will offset losses from the drop in Alnylam Pharmaceuticals' long position.The idea behind Eyepoint Pharmaceuticals and Alnylam Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
| Alnylam Pharmaceuticals vs. ProQR Therapeutics BV | Alnylam Pharmaceuticals vs. Wave Life Sciences | Alnylam Pharmaceuticals vs. Blueprint Medicines Corp | Alnylam Pharmaceuticals vs. Apellis Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Other Complementary Tools
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |